Latest period
$25.26M
YoY change
-50.7%
5Y CAGR
-9.7%
Peak year (2024)
$62.88M
Cumulative CapEx
$619.02M
CapEx history chart for Bio-Techne (TECH) from 1990 to 2025
Latest: $31.01M
CapEx growth chart for Bio-Techne (TECH) from 1990 to 2025
Latest: -50.7%
CapEx history table for Bio-Techne (TECH) from 1990 to 2025
| 2025 | $31.01M | -50.7% | −$31.87M | ||
| 2024 | $62.88M | +64.4% | +$24.63M | ||
| 2023 | $38.24M | -14.8% | −$6.66M | ||
| 2022 | $44.91M | +1.4% | +$607.00K | ||
| 2021 | $44.30M | -14.4% | −$7.44M | ||
| 2020 | $51.74M | +103.6% | +$26.33M | ||
| 2019 | $25.41M | +21.4% | +$4.48M | ||
| 2018 | $20.93M | +37.9% | +$5.75M | ||
| 2017 | $15.18M | -10.2% | −$1.72M | ||
| 2016 | $16.90M | -15.1% | −$3.01M | ||
| 2015 | $19.91M | +44.0% | +$6.08M | ||
| 2014 | $13.82M | -38.4% | −$8.63M | ||
| 2013 | $22.45M | +273.2% | +$16.44M | ||
| 2012 | $6.02M | +65.8% | +$2.39M | ||
| 2011 | $3.63M | -21.8% | −$1.01M | ||
| 2010 | $4.64M | -29.2% | −$1.91M | ||
| 2009 | $6.56M | -59.9% | −$9.81M | ||
| 2008 | $16.36M | +102.6% | +$8.29M | ||
| 2007 | $8.08M | +75.5% | +$3.47M | ||
| 2006 | $4.60M | -59.7% | −$6.81M | ||
| 2005 | $11.41M | +207.5% | +$7.70M | ||
| 2004 | $3.71M | -75.6% | −$11.48M | ||
| 2003 | $15.19M | -31.8% | −$7.08M | ||
| 2002 | $22.28M | +226.9% | +$15.46M | ||
| 2001 | $6.81M | -77.6% | −$23.55M | ||
| 2000 | $30.37M | -0.8% | −$232.14K | ||
| 1999 | $30.60M | +920.0% | +$27.60M | ||
| 1998 | $3.00M | -28.6% | −$1.20M | ||
| 1997 | $4.20M | -34.4% | −$2.20M | ||
| 1996 | $6.40M | +392.3% | +$5.10M | ||
| 1995 | $1.30M | 0.0% | $0.00 | ||
| 1994 | $1.30M | -50.0% | −$1.30M | ||
| 1993 | $2.60M | +333.3% | +$2.00M | ||
| 1992 | $600.00K | -33.3% | −$300.00K | ||
| 1991 | $900.00K | +125.0% | +$500.00K | ||
| 1990 | $400.00K | — | — |
- 2025$31.01M-50.7%
- 2024$62.88M+64.4%
- 2023$38.24M-14.8%
- 2022$44.91M+1.4%
- 2021$44.30M-14.4%
- 2020$51.74M+103.6%
- 2019$25.41M+21.4%
- 2018$20.93M+37.9%
- 2017$15.18M-10.2%
- 2016$16.90M-15.1%
- 2015$19.91M+44.0%
- 2014$13.82M-38.4%
- 2013$22.45M+273.2%
- 2012$6.02M+65.8%
- 2011$3.63M-21.8%
- 2010$4.64M-29.2%
- 2009$6.56M-59.9%
- 2008$16.36M+102.6%
- 2007$8.08M+75.5%
- 2006$4.60M-59.7%
- 2005$11.41M+207.5%
- 2004$3.71M-75.6%
- 2003$15.19M-31.8%
- 2002$22.28M+226.9%
- 2001$6.81M-77.6%
- 2000$30.37M-0.8%
- 1999$30.60M+920.0%
- 1998$3.00M-28.6%
- 1997$4.20M-34.4%
- 1996$6.40M+392.3%
- 1995$1.30M0.0%
- 1994$1.30M-50.0%
- 1993$2.60M+333.3%
- 1992$600.00K-33.3%
- 1991$900.00K+125.0%
- 1990$400.00K—
CapEx values are taken from Bio-Techne's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's current CapEx (TTM) is $25.26M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual CapEx for Bio-Techne (TECH) came in at $31.01M – plunged 50.7% year-over-year.
Across 2020–2025 (5 years), Bio-Techne CapEx produced a CAGR of -9.7% – with a net decline across the window.
Between 2024 and 2025, Bio-Techne CapEx plunged 50.7%, falling from $62.88M to $31.01M.
Across the available history, CapEx reached its high of $62.88M in 2024 and its low of $400.00K in 1990.
Bio-Techne Capital Expenditures by Year
Bio-Techne Capital Expenditures 2025: $31.01M
Bio-Techne CapEx in 2025 was $31.01M, plunged 50.7% below 2024.
Bio-Techne Capital Expenditures 2024: $62.88M
2024's CapEx for Bio-Techne came in at $62.88M, surged 64.4% from 2023. This figure represents the highest annual value in the available history.
Bio-Techne Capital Expenditures 2023: $38.24M
Bio-Techne posted CapEx of $38.24M in 2023, declined 14.8% below 2022.
Bio-Techne Capital Expenditures 2022: $44.91M
In 2022, Bio-Techne reported CapEx of $44.91M, edged up 1.4% from 2021.
Bio-Techne Capital Expenditures 2021: $44.30M
Bio-Techne CapEx in 2021 was $44.30M.
See more financial history for Bio-Techne (TECH).
Sector peers by CapEx
Healthcare peers of Bio-Techne (TECH), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $5.91B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $5.91B
- $4.83B
- $4.11B
- $3.62B
- $1.86B
- $1.21B
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation